{"entity":{"type":"insider","cik":"0001799304","url":"/insider/0001799304","json_url":"/insider/0001799304.json","name":"Ahmed Mahiuddin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2020-05-13","last":"2020-05-27","span_basis":"filed_date"},"name_variants":[{"name":"Ahmed Mahiuddin","source":"filing","n_filings":4,"first_seen":"2020-05-13","last_seen":"2020-05-27"}],"transactions":[{"id":2339728,"accession":"0001104659-20-066408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-066408","line_url":"/filing/0001104659-20-066408#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001799304","owner_name":"Ahmed Mahiuddin","owner_display_name":"Ahmed Mahiuddin","owner_url":"/insider/0001799304","role":"Officer (Sr. VP and CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":39.3847,"price_display":"39.38","price_state":"stated","total_value":1969235.0,"total_display":"1,969,235.00","total_whole":"1,969,235","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-27","scope":"insider"},{"id":2801669,"accession":"0001104659-20-064258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-064258","line_url":"/filing/0001104659-20-064258#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001799304","owner_name":"Ahmed Mahiuddin","owner_display_name":"Ahmed Mahiuddin","owner_url":"/insider/0001799304","role":"Officer (Sr. VP and CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":39.2403,"price_display":"39.24","price_state":"stated","total_value":392403.0,"total_display":"392,403.00","total_whole":"392,403","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-20","scope":"insider"},{"id":2801663,"accession":"0001104659-20-064258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-064258","line_url":"/filing/0001104659-20-064258#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001799304","owner_name":"Ahmed Mahiuddin","owner_display_name":"Ahmed Mahiuddin","owner_url":"/insider/0001799304","role":"Officer (Sr. VP and CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19492.0,"shares_display":"19,492","price_per_share":39.4867,"price_display":"39.49","price_state":"stated","total_value":769674.7564,"total_display":"769,674.76","total_whole":"769,675","shares_owned_after":210000.0,"shares_owned_after_display":"210,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2862653,"accession":"0001104659-20-062619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-062619","line_url":"/filing/0001104659-20-062619#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001799304","owner_name":"Ahmed Mahiuddin","owner_display_name":"Ahmed Mahiuddin","owner_url":"/insider/0001799304","role":"Officer (Sr. VP & Chief Scientific Off)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Scientific Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Scientific Off","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10508.0,"shares_display":"10,508","price_per_share":37.644,"price_display":"37.64","price_state":"stated","total_value":395563.152,"total_display":"395,563.15","total_whole":"395,563","shares_owned_after":229492.0,"shares_owned_after_display":"229,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider"},{"id":2862641,"accession":"0001104659-20-060887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-060887","line_url":"/filing/0001104659-20-060887#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001799304","owner_name":"Ahmed Mahiuddin","owner_display_name":"Ahmed Mahiuddin","owner_url":"/insider/0001799304","role":"Officer (Sr. VP and CSO)","role_mark":"O","role_mark_label":"Officer (Sr. VP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.1888,"price_display":"39.19","price_state":"stated","total_value":783776.0,"total_display":"783,776.00","total_whole":"783,776","shares_owned_after":240000.0,"shares_owned_after_display":"240,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Officer (Sr. VP and CSO)","n_filings":4,"first_seen":"2020-05-13","last_seen":"2020-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799304","retrieved_at":"2026-08-25T18:04:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}